WallStreetZenWallStreetZen

NASDAQ: GMAB
Genmab A Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for GMAB

Based on 7 analysts offering 12 month price targets for Genmab A

Min Forecast
$34.00+23.73%
Avg Forecast
$40.93+48.94%
Max Forecast
$48.00+74.67%

Should I buy or sell GMAB stock?

Based on 7 analysts offering ratings for Genmab A.

Strong Buy
Strong Buy
5 analysts 71.43%
Buy
1 analysts 14.29%
Hold
1 analysts 14.29%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although GMAB's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates GMAB as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their GMAB stock forecasts and price targets.

GMAB stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-03-02
lockedlocked$00.00+00.00%2026-02-23
lockedlocked$00.00+00.00%2026-02-18
lockedlocked$00.00+00.00%2026-02-17
lockedlocked$00.00+00.00%2026-02-16
Truist Securities
Bottom 8%
8
Strong BuyReiterates$48.00+74.67%2025-11-07
Guggenheim
Top 17%
84
Strong BuyUpgrades$43.00+56.48%2025-09-24

1 of 1

GMAB vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
GMAB$27.48$40.93+48.94%Strong Buy
INCY$97.33$109.71+12.72%Buy
RVMD$99.64$119.36+19.79%Strong Buy
ASND$237.35$282.91+19.19%Strong Buy
UTHR$485.06$568.63+17.23%Buy
View Top Biotech Stocks

Genmab A Stock Forecast FAQ

Is Genmab A Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NASDAQ: GMAB) stock is to Strong Buy GMAB stock.

Out of 7 analysts, 5 (71.43%) are recommending GMAB as a Strong Buy, 1 (14.29%) are recommending GMAB as a Buy, 1 (14.29%) are recommending GMAB as a Hold, 0 (0%) are recommending GMAB as a Sell, and 0 (0%) are recommending GMAB as a Strong Sell.

If you're new to stock investing, here's how to buy Genmab A stock.

What is GMAB's Price Target?

According to 7 Wall Street analysts that have issued a 1 year GMAB price target, the average GMAB price target is $40.93, with the highest GMAB stock price forecast at $48.00 and the lowest GMAB stock price forecast at $34.00.

On average, Wall Street analysts predict that Genmab A's share price could reach $40.93 by Mar 2, 2027. The average Genmab A stock price prediction forecasts a potential upside of 48.94% from the current GMAB share price of $27.48.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.